A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, PK and Immunogenicity of YBSW015 in Healthy Subjects
NCT05369754
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronavirus Disease 2019
Interventions
BIOLOGICAL:
YBSW015 injection
Sponsor
Yabao Pharmaceutical Group